Keyphrases
HIV Patients
100%
Sub-Saharan Africa
100%
HIV-1 Infection
100%
Controller
100%
Non-progression
100%
Epidemiology
50%
Vaccine Development
50%
Next-generation Vaccines
50%
New Therapeutics
50%
Clinical Management
50%
Europe
50%
HIV-positive
50%
Therapeutic Development
50%
Elite Controllers
50%
Resource-limited Settings
50%
Long-term Nonprogressors
50%
Long-term Nonprogression
50%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus 1 Infection
100%
Cohort Effect
33%
Clinical Management
33%
Vaccine Development
33%
Long-Term Nonprogressor
33%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus 1
100%
Vaccine Efficacy
33%